The survival of California’s dialysis clinics is in the hands of its voters this November. Sound familiar?

While COVID-19 infections spike uncontrollably across the country, California has turned the corner.

This Election Day, California voters are being asked to replenish funding for the state’s ambitious stem cell research program, with a well-financed campaign that’s making heady promises about curing diabetes, paralysis, cancer, and Parkinson’s and Alzheimer’s diseases.

The Trump administration has updated its reporting requirements for COVID-19 provider relief funds following pushback.

As COVID-19 took hold in March, U.S. doctors limited in-person appointments — and many patients avoided them — for fear of infection. The result was a huge increase in the volume of remote medical and behavioral health visits.

Most insurers on the Affordable Care Act’s (ACA's) insurance exchanges aren’t factoring COVID-19 into their 2021 rates or believe the pandemic will have a negligible effect, according to several experts.